Associations Between Mammography and Ultrasound Imaging Features and Molecular Characteristics of Triple-negative Breast Cancer |
Li, Bo
(Department of Ultrasound, The Third Affiliated Hospital of Harbin Medical University)
Zhao, Xin (Department of Surgery, The Second Affiliated Hospital of Harbin Medical University) Dai, Shao-Chun (Department of Ultrasound, The Third Affiliated Hospital of Harbin Medical University) Cheng, Wen (Department of Ultrasound, The Third Affiliated Hospital of Harbin Medical University) |
1 | Reis-Filho JS, Tutt AN (2008). Triple negative tumours: a critical review. Histopathology, 52, 108-18. |
2 | Claus EB, Petruzella S, Matloff E, Carter D (2005). Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. JAMA, 293, 964-9. DOI ScienceOn |
3 | Bottini A, Berruti A, Bersiga A, et al (2001). Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer. Br J Cancer, 85, 1106-12. DOI ScienceOn |
4 | Carey LA, Perou CM, Livasy CA, et al (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 295, 2492-502. DOI ScienceOn |
5 | Chae BJ, Bae JS, Lee A, et al (2009). p53 as a specific prognostic factor in triple-negative breast cancer. Jpn J Clin Oncol, 39, 217-24. DOI ScienceOn |
6 | Cleator S, Heller W, Coombes RC (2007). Triple-negative breast cancer: therapeutic options. Lancet Oncol, 8, 235-44. DOI ScienceOn |
7 | Crook T, Crossland S, Crompton MR, Osin P, Gusterson BA (1997). p53 mutations in BRCA1-associated familial breast cancer. Lancet, 350, 638-9. |
8 | Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT (2010). Multimodality imaging of triple receptornegative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol, 194, 1160-6. DOI ScienceOn |
9 | Doreen C, Donovan A (2011). Triple negative breast cancer: therapeutic and prognostic implications. Asian Pac J Cancer Prev, 12, 2129-33. |
10 | Itoh A, Ueno E, Tohno E, et al (2006). Breast disease: clinical application of US elastography for diagnosis. Radiology, 239, 341-50. DOI ScienceOn |
11 | Somali I, Ustaoglu BY, Tarhan MO, et al (2013). Clinicopathologic and demographic evaluation of triple- negative breast cancer patients among a turkish patient population: a single center experience. Asian Pac J Cancer Prev, 14, 6013-7. 과학기술학회마을 DOI ScienceOn |
12 | Tang J, Wu CC, Xie ZM, Luo RZ, Yang MT (2011). Comparison of Clinical Features and Treatment Outcome of Breast Cancers in Young and Elderly Chinese Patients. Breast Care (Basel), 6, 435-40. DOI ScienceOn |
13 | Yang WT, Dryden M, Broglio K, et al (2008). Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat, 111, 405-10. DOI ScienceOn |
14 | Li CY, Zhang S, Zhang XB, et al (2013). Clinicopathological and prognostic characteristics of triple-negative breast cancer (TNBC) in Chinese patients: a retrospective study. Asian Pac J Cancer Prev, 14, 3779-84. 과학기술학회마을 DOI ScienceOn |
15 | Keam B, Im SA, Lee KH, et al (2011). Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis. Breast Cancer Res, 13, 22. |
16 | Kim MJ, Ro JY, Ahn SH, et al (2006). Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neuoverexpressing phenotypes. Hum Pathol, 37, 1217-26. DOI ScienceOn |
17 | Lerma E, Peiro G, Ramon T, et al (2007). Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas). Mod Pathol, 20, 1200-7. DOI ScienceOn |
18 | Ma H, Luo J, Press MF, et al (2009). Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev, 18, 479-85. DOI ScienceOn |
19 | Noguchi S, Kasugai T, Miki Y, et al (1999). Clinicopathologic analysis of BRCA-1 or BRCA-2 associated hereditary breast carcinoma in Japanese women. Cancer, 85, 2200-5. DOI |
20 | Perou CM, Sorlie T, Eisen MB, et al (2000). Molecular portraits of human breast tumours. Nature, 406, 747-52. DOI ScienceOn |
21 | Phipps AI, Buist DS, Malone KE, et al (2012). Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol, 22, 340-8. |
22 | Foulkes WD, Smith IE, Reis-Filho JS (2010). Triple-negative breast cancer. N Engl J Med, 363, 1938-48. DOI ScienceOn |
23 | Sachdev JC, Ahmed S, Mirza MM, et al (2010). Does race affect outcomes in triple negative breast cancer? Breast Cancer (Auckl), 4, 23-33. |